About
Videos News Careers Contact Providers Investors Explore Felix
Clinical Evidence & Media

Clinical Videos & Expert Insights

Watch direct clinical evaluations from movement disorder specialists and real-world outcomes using the FDA-cleared Felix NeuroAI™ Wristband.

Innovation Overview

A Revolutionary AI Therapeutic for Movement Disorders

For years, medical professionals and patients have anticipated the convergence of artificial intelligence and bioelectronic medicine. Felix NeuroAI™ represents a major clinical milestone: an FDA-cleared, 100% noninvasive prescription therapy engineered for adult essential tremor management.

By capturing peripheral neuromuscular signals at the wrist and processing them through proprietary cloud-based AI algorithms, Felix delivers closed-loop modulation tailored to each patient's evolving tremor dynamics.

Medical Expertise & Validation

Movement Disorder Specialists on Felix

Principal investigators and leading clinical neurologists share trial observations, clinical efficacy, and patient quality-of-life enhancements.

“I was a principal investigator in the randomized sham-controlled trial. After 90 days, the unblinded trial data demonstrated results significantly favoring the active therapeutic device. Felix effectively fills the critical therapeutic gap between oral pharmacotherapy and deep brain surgery.”

William Ondo, MD
Director, Movement Disorders Clinic at Methodist Neurological Institute
Professor of Neurology, Weill Cornell Medical School

“Essential tremor severely restricts daily functional activities. Across both our open-label pilot and double-blind sham-controlled clinical trials, adaptive closed-loop AI stimulation consistently yielded objective tremor score improvements alongside superior safety profiles.”

Rajesh Pahwa, MD
Professor & Chief, Parkinson and Movement Disorder Division
University of Kansas Medical Center

“The integration of AI to continuously personalize neuromodulation represents a fundamental step forward. In rigorous clinical evaluations, Fasikl demonstrated meaningful hand tremor reduction without systemic drug side effects or surgical risks.”

Stuart H. Isaacson, MD
Director, Parkinson’s Disease and Movement Disorders Center of Boca Raton

“Essential tremor affects millions worldwide, yet traditional pharmacological treatments are frequently limited by intolerance. Properly calibrated neural AI algorithms optimize stimulation patterns to deliver measurable therapeutic benefit.”

Richard B. Dewey Jr., MD
Movement Disorder Specialist & Clinical Researcher
Real-World Evidence

Patient Stories: Restoring Functional Independence

Observational feedback and long-term daily experience from individuals using Felix for noninvasive hand tremor relief.

“Having an active, noninvasive system monitoring and modulating my neural signals in real time has dramatically reduced my hand tremors during daily tasks.”

David & Lisa
Essential Tremor Patient Case Study

“It achieves therapeutic results comparable to surgical efficacy without requiring invasive procedures. My motor stability and personal independence have been restored.”

Christian
Essential Tremor Patient Case Study

“My physician recommended surgical options after drug therapies failed. Felix offered a comfortable, non-pharmacological alternative that enabled me to resume fine motor activities.”

Cindy
Essential Tremor Patient Case Study

“After one month of consistent therapy, I regained the fine motor stability required to handle daily objects smoothly without spills or tremors.”

Steve
Former Electrician & Essential Tremor Patient
International Business Cooperation

Partner with Fasikl for Global Neuro-AI Distribution

Fasikl actively collaborates with international medical device distributors, hospital procurement directors, and neurological research institutions to expand access to FDA-cleared Neuro-AI therapeutics worldwide.

Contact Us